Qiubai Li

Union Hospital, 
Wuhan, CN 
Union Hospital, 
Wuhan, CN 

Overview

Qiubai Li practices practicing medicine in Wuhan, China.

Their clinical expertise encompasses Acute Megakaryoblastic Leukemia, Plasmacytoma, Acute Myeloid Leukemia (AML), and Leukemia.

They are actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 1 clinical trial.

Locations

Union Hospital, Wuhan, 430022, China
Other Locations
Hubei Bioinformatics &Molecular Imaging Key Laboratory, Wuhan, 430074, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Open-label, Phase 1/2a Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
A Multicenter, Open-label, Phase 1/2a Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Enrollment Status: Completed
Publish Date: April 15, 2024
Intervention Type: Drug
Study Drugs: TJ011133, Azacitidine
Study Phase: Phase 1/Phase 2

32 Total Publications

Size-Based Proteomic Signatures of Extracellular Vesicles Derived from Umbilical Cord Mesenchymal Stem Cells Fractionated by EXODUS.
Size-Based Proteomic Signatures of Extracellular Vesicles Derived from Umbilical Cord Mesenchymal Stem Cells Fractionated by EXODUS.
Journal: International journal of molecular sciences
Published: July 03, 2026

Frequently Asked Questions about Qiubai Li

Is Qiubai Li a top-rated expert for Acute Megakaryoblastic Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Qiubai Li is classified as an Experienced expert for Acute Megakaryoblastic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Qiubai Li participate in research or clinical trials?

Yes. Qiubai Li has published 32 articles and abstracts on conditions like Acute Megakaryoblastic Leukemia. You can view a list of Qiubai Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile